top of page
Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
Jumatano, 15 Julai 2026, 2:43:25 GMT +3
Medicines Affecting Coagulation
Medicines Affecting Coagulation
Name of drug | Dosage forms and Strengths | Level of medicine |
Etamsylate | Tablet 500mg | C |
Low molecular Weight heparin | Injection 100mg/mL | S |
Phytomenadione (Vit K1) | Injection 0.5 mg/mL, 2mg/mL in 2mL ampoule; | B |
Protamine sulfate | Injection 10mg/mL in 5mL ampoule | B |
Rivaroxaban | Tablet 15mg, 20mg | S |
Unfractionated Heparin Sodium | Injection (sodium salt) 1,000 IU/mL in 5mL ampoule | B (Under specialist supervision) |
Tranexamic acid | Injection 100mg/mL in 5mL ampoule; Syrup 500mg/5mL in 300mL bottle; Tablet 500mg | C |
Warfarin | Tablet: 1mg; 2mg; 5mg (sodium salt) | C |
Imeandikwa:
Alhamisi, 4 Juni 2026, 9:58:13 GMT +3
References:
bottom of page

